CTOs on the Move

Madrigal Pharmaceuticals

www.madrigalpharma.com

 
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need. The Company has advanced its lead candidate, resmetirom, also known as MGL-3196, a first-in-class, orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) β-selective agonist, through Phase 2 clinical trials in NASH. Primary and key secondary endpoints were achieved including reduction of liver fat on a sensitive non-invasive imaging test, lowering of multiple atherogenic lipids including LDL-cholesterol and triglycerides, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Ronald Filippo
Chief Information Officer Profile
Dominic Labriola
Chief Data and Analytics Officer Profile
Nicole Rosenberger
Vice President, Head of Information Technology Profile

Jobs

Chief Information Security Officer

Madrigal Pharmaceuticals Conshohocken, PA

Chief Information Security Officer

Madrigal Pharmaceuticals Conshohocken, PA

Funding

Madrigal Pharmaceuticals raised $250M on 05/09/2022

Similar Companies

River Remedy

River Remedy is a medical cannabis company dedicated to serving Mississippi patients with the highest quality plant based medicine.

Clearside Biomedical

Clearside Biomedical, Inc. is a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat chronic, blinding diseases of the eye.

Novum

Novum is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reed'S Pharmacy

Reed'S Pharmacy is a Berkeley Springs, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osmind

Osmind is building the digital infrastructure for the next era of mental health. Osmind EHR is the #1 software for treatment-resistant mental health practices such as those in psychiatry, ketamine, psychedelic medicine, and neuromodulation.